Speranțe uriașe pentru o pastilă contra cancerului pancreatic, după ce tumorile au dispărut în timpul unui studiu
A new pill shows promise in shrinking pancreatic tumors, with some patients experiencing complete remission during trials. Experts call it a significant breakthrough in pancreatic cancer treatment. While 90% of participants saw tumor growth halt, only a small percentage achieved undetectable tumors. The drug, daraxonrasib, targets specific mutations linked to cancer progression. Despite the encouraging results, long-term effectiveness remains uncertain, and it is not yet a cure.
Fact-check this story: paste the text or link into Justificat.ro and get a verdict with the sources consulted.